‘Why millennials like me are choosing to stay sober in lockdown’
A fifth of adults are drinking more as the pandemic restrictions continue, but young people are bucking the trend
10 February 2021 • 10:00am
Millie Gooch: ‘Social media plays a part in the uptick of non-drinkers’
Credit: Emily Metcalfe for The Telegraph
According to recent research into pandemic drinking habits by Alcohol Change UK, one in five people are drinking more during lockdown. Happily, I am not one of them. In fact, I don’t drink alcohol at all because three years ago, after noticing the negative toll that drinking and subsequent hangovers was having on my mental health, I made the decision to go teetotal, at the age of 26.
Think about why you drink. Kamala Greene Génecé, a psychologist who specializes in addiction, says it s important to look at the role alcohol plays in your life. That will allow you to make specific changes based on the information that you gather, she says. There s no need for judgment, but R. Lorraine Collins, a psychologist at the University of Buffalo, recommends asking yourself, Are you keeping alcohol as . a special beverage for limited situations, or are you engaging in alcohol use across the board?
Track how much you drink. The U.S. Department of Health and Human Services recommends that if you drink, you should do it moderately: up to one drink a day for women or two drinks for men. But Collins says sometimes people can get confused by what constitutes a drink. For many people . in their minds, a glass equals a drink, she says. So it s important to assess not just
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
News provided by
Share this article
Share this article
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference.
Highlights
Presenting long-term strategic initiatives and growth outlook
Projecting 2021 global sales of $4.9-5.3 billion; underlying growth in the mid-teens
Projecting 2021 TAVR sales of $3.2-3.6 billion; underlying growth 15-20%
Estimating 2021 adjusted earnings per share $2.00-2.20 Putting patients first has never been more important than it is in 2020, and I am humbled by the agility, resourcefulness and passion of our partners and employees in maintaining their important work on behalf of patients during this particularly difficult time, said Michael A. Mussallem, chai